Literature DB >> 7953058

Neuropathological correlates of psychotic phenomena in confirmed Alzheimer's disease.

H Förstl1, A Burns, R Levy, N Cairns.   

Abstract

BACKGROUND: The prevalence of psychotic phenomena in confirmed Alzheimer's disease (AD) and their potential neuropathological correlates have rarely been the subject of prospective investigation.
METHOD: Psychopathological disturbances were recorded prospectively according to the Geriatric Mental State Schedule and the CAMDEX: The frequency of these phenomena and neuropathological changes were examined in 56 patients with definite AD.
RESULTS: Hallucinations had been documented in 13 patients, paranoid delusions in 9 and delusional misidentification (e.g. the Capgras-type and the 'phantom boarder' symptoms) in 14 patients. Misidentifications were associated with lower neurone counts in the area CA1 of the hippocampus. Delusions and hallucinations were observed in patients with less severe cell loss in the parahippocampal gyrus and with lower cell counts in the dorsal raphe nucleus. A decrease of neurones in the locus coeruleus in a subset of depressed patients with AD had been reported earlier. Delusions and delusional misidentification were common in 5 patients with basal ganglia mineralisation, but there was no statistically significant association of these symptoms with the presence of Lewy bodies in the brainstem and neocortex of our patient sample.
CONCLUSIONS: These findings are compatible with the view that morphological changes in certain brain areas may promote the development of psychotic phenomena in AD. AD may offer a model for the understanding of pathomechanisms underlying the development of psychopathological disturbances in other psychoses with more discrete neuropathological changes.

Entities:  

Mesh:

Year:  1994        PMID: 7953058     DOI: 10.1192/bjp.165.1.53

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  43 in total

Review 1.  Neuropsychiatric aspects of Alzheimer's disease.

Authors:  C Ballard; M Walker
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

2.  Treating behavioural and psychological signs in Alzheimer's disease.

Authors:  C Ballard; J O'Brien
Journal:  BMJ       Date:  1999-07-17

3.  Clinical characteristics of community-dwelling black Alzheimer's disease patients.

Authors:  D G Harwood; W W Barker; R L Ownby; R Duara
Journal:  J Natl Med Assoc       Date:  2000-09       Impact factor: 1.798

Review 4.  Turning on the Light Within: Subcortical Nuclei of the Isodentritic Core and their Role in Alzheimer's Disease Pathogenesis.

Authors:  Panos Theofilas; Sara Dunlop; Helmut Heinsen; Lea Tenenholz Grinberg
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

5.  An initial study of modifiable and non-modifiable factors for late-life psychosis.

Authors:  Obiora E Onwuameze; Susan K Schultz; Sergio Paradiso
Journal:  Int J Psychiatry Med       Date:  2011       Impact factor: 1.210

6.  No association of psychosis in Alzheimer disease with neurodegenerative pathway genes.

Authors:  Mary Ann A DeMichele-Sweet; Lambertus Klei; Bernie Devlin; Robert E Ferrell; Elise A Weamer; James E Emanuel; Oscar L Lopez; Robert A Sweet
Journal:  Neurobiol Aging       Date:  2010-11-18       Impact factor: 4.673

7.  Of mind and matter--or what really matters in Alzheimer's disease? Neurobiological substrates of clinical deficits in Alzheimer's disease.

Authors:  H Förstl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

Review 8.  Neuropathological and neuroradiological correlates of paranoid symptoms in organic mental disease.

Authors:  A Burns; H Forstl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

9.  Differentiated clinical presentation of early and late-onset Alzheimer's disease: is 65 years of age providing a reliable threshold?

Authors:  Antonio Palasí; Belén Gutiérrez-Iglesias; Montse Alegret; Francesc Pujadas; Mikel Olabarrieta; Diana Liébana; Manolo Quintana; José Álvarez-Sabín; Mercè Boada
Journal:  J Neurol       Date:  2015-03-21       Impact factor: 4.849

10.  Gray matter atrophy in patients with mild cognitive impairment/Alzheimer's disease over the course of developing delusions.

Authors:  Corinne E Fischer; Windsor Kwan-Chun Ting; Colleen P Millikin; Zahinoor Ismail; Tom A Schweizer
Journal:  Int J Geriatr Psychiatry       Date:  2015-03-27       Impact factor: 3.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.